Literature DB >> 24860613

Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Jane Z Kuo1, Tien Y Wong2, Frank S Ong3.   

Abstract

Entities:  

Year:  2013        PMID： 24860613      PMCID： PMC4029770          DOI： 10.1586/eop.13.3

Source DB:  PubMed          Journal:  Expert Rev Ophthalmol        ISSN： 1746-9899


× No keyword cloud information.
  113 in total

1.  Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

Authors:  Daniel E Weeks; Yvette P Conley; Hui-Ju Tsai; Tammy S Mah; Silke Schmidt; Eric A Postel; Anita Agarwal; Jonathan L Haines; Margaret A Pericak-Vance; Philip J Rosenfeld; T Otis Paul; Andrew W Eller; Lawrence S Morse; J P Dailey; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2004-05-27       Impact factor: 11.025

2.  Toll-like receptor 3 polymorphism rs3775291 is not associated with choroidal neovascularization or polypoidal choroidal vasculopathy in Chinese subjects.

Authors:  Chelvin C A Sng; Peter D Cackett; Ian Y Yeo; Anbupalam Thalamuthu; Anandalakshmi Venkatraman; Divya Venkataraman; Adrian H Koh; E-Shyong Tai; Tien Y Wong; Tin Aung; Eranga N Vithana
Journal:  Ophthalmic Res       Date:  2010-11-16       Impact factor: 2.892

3.  Susceptibility genes for age-related maculopathy on chromosome 10q26.

Authors:  Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Tammy S Mah; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2005-07-26       Impact factor: 11.025

4.  Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population.

Authors:  Satoshi Arakawa; Atsushi Takahashi; Kyota Ashikawa; Naoya Hosono; Tomomi Aoi; Miho Yasuda; Yuji Oshima; Shigeo Yoshida; Hiroshi Enaida; Takashi Tsuchihashi; Keisuke Mori; Shigeru Honda; Akira Negi; Akira Arakawa; Kazuaki Kadonosono; Yutaka Kiyohara; Naoyuki Kamatani; Yusuke Nakamura; Tatsuro Ishibashi; Michiaki Kubo
Journal:  Nat Genet       Date:  2011-09-11       Impact factor: 38.330

5.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.

Authors:  Martin McKibbin; Manir Ali; Shveta Bansal; Paul D Baxter; Kumi West; Grange Williams; Frances Cassidy; Chris F Inglehearn
Journal:  Br J Ophthalmol       Date:  2011-05-10       Impact factor: 4.638

7.  Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center.

Authors:  Sepideh Zareparsi; Adam C Reddick; Kari E H Branham; Kathryn B Moore; Laurie Jessup; Susan Thoms; Michael Smith-Wheelock; Beverly M Yashar; Anand Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-05       Impact factor: 4.799

8.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.

Authors:  Milam A Brantley; Amy M Fang; Jennifer M King; Asheesh Tewari; Steven M Kymes; Alan Shiels
Journal:  Ophthalmology       Date:  2007-12       Impact factor: 12.079

9.  Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.

Authors:  Yi Yu; Tushar R Bhangale; Jesen Fagerness; Stephan Ripke; Gudmar Thorleifsson; Perciliz L Tan; Eric H Souied; Andrea J Richardson; Joanna E Merriam; Gabriëlle H S Buitendijk; Robyn Reynolds; Soumya Raychaudhuri; Kimberly A Chin; Lucia Sobrin; Evangelos Evangelou; Phil H Lee; Aaron Y Lee; Nicolas Leveziel; Donald J Zack; Betsy Campochiaro; Peter Campochiaro; R Theodore Smith; Gaetano R Barile; Robyn H Guymer; Ruth Hogg; Usha Chakravarthy; Luba D Robman; Omar Gustafsson; Haraldur Sigurdsson; Ward Ortmann; Timothy W Behrens; Kari Stefansson; André G Uitterlinden; Cornelia M van Duijn; Johannes R Vingerling; Caroline C W Klaver; Rando Allikmets; Milam A Brantley; Paul N Baird; Nicholas Katsanis; Unnur Thorsteinsdottir; John P A Ioannidis; Mark J Daly; Robert R Graham; Johanna M Seddon
Journal:  Hum Mol Genet       Date:  2011-06-10       Impact factor: 6.150

10.  Impact of loading phase, initial response and CFH genotype on the long-term outcome of treatment for neovascular age-related macular degeneration.

Authors:  Moreno Menghini; Barbara Kloeckener-Gruissem; Johannes Fleischhauer; Malaika M Kurz-Levin; Florian K P Sutter; Wolfgang Berger; Daniel Barthelmes
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240
View more
  6 in total

1.  Association of HERPUD1 genetic variant rs2217332 with age-related macular degeneration and polypoidal choroidal vasculopathy in an Indian cohort.

Authors:  Lakshmi Priyankka Alagappan; Yazhini Ramaswamy; Deepak Kumar Sundaramoorthy; Joshitha Bhaskar; Sripriya Sarangapani; Parveen Sen; Rajiv Raman; Muna Bhende; Sinnakaruppan Mathavan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-12       Impact factor: 3.535

Review 2.  Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

Review 3.  The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.

Authors:  Kelvin Yi Chong Teo; Mark Gillies; Samantha Fraser-Bell
Journal:  Int J Mol Sci       Date:  2018-09-03       Impact factor: 5.923

Review 4.  Association of Genes in the High-Density Lipoprotein Metabolic Pathway with Polypoidal Choroidal Vasculopathy in Asian Population: A Systematic Review and Meta-Analysis.

Authors:  Ming-Zhen Yuan; Ruo-An Han; Chen-Xi Zhang; You-Xin Chen
Journal:  J Ophthalmol       Date:  2018-06-06       Impact factor: 1.909

Review 5.  CRISPR/Cas9-A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects.

Authors:  Irshad Ahmad
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

6.  Peripapillary Choroidal Thickness Change of Polypoidal Choroidal Vasculopathy after Anti-vascular Endothelial Growth Factor.

Authors:  Kyou Ho Lee; Seo Hee Kim; Ji Min Lee; Eui Chun Kang; Hyoung Jun Koh
Journal:  Korean J Ophthalmol       Date:  2017-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.